Immunovia AB (publ) CEO Transition - Conference Call Transcript
()-
Great. Welcome to this teleconference with Immunovia in relation to this morning's press release, where we announced the transition of the CEO position. I will just give you a short background, and then Mats will give -- say a few words, and then we open for question, which is really the reason we're here.
So as you know, we started some 7 years ago with an idea from academia, CREATE Health, the translational cancer center, which has now grown into a full-fledged and one of the most advanced diagnostic companies based on multiplex diagnosis of complex disease. And Mats has really built this company from the idea we had some years ago into this company we have today and with help of staff and Board, of course, into something we all think is quite successful. And very much looking forward to the launch of the first product in Q4.
I've been working with succession for quite a while because it's -- finding an experienced and seasoned successor to Mats is -- has been a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
